Home
Conditions
Progressive Disease

Clinical trial condition

Progressive Disease

Explore clinical trials studying Progressive Disease. Study availability and eligibility vary by location and protocol.

10 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Progressive Disease trial results

Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

NCT04954820

Conditions: Disease Attributes, Disease Progression, Intestinal Well Differentiated Endocrine Tumor, +9 more
Locations: Institut de Cancérologie de l'Ouest Site d'Angers Angers, France

Institut Bergonié Bordeaux, France

CHRU Morvan Brest, France

Hospices civils de LYON - GHE Bron, France

View all 28 locations

View Trial Details

Recruiting

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

NCT07560865

Conditions: Astrocytoma, Disease Attributes, Disease Progression, +12 more
Locations: Elizabeth C. Neil, MD Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT

NCT06900777

Conditions: Child, Disease Attributes, Disease Progression, +8 more
Locations: Xijing Hospital Xi'an, Shaanxi, China

View Trial Details

Not yet recruiting

Symptom Trajectory Approaches to Research

NCT07804875

Conditions: Advanced Cancer, Cancer Treatment, Disease Attributes, +10 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

New York -Presbyterian Morgan Stanley Children's Hospital New York, United States

Nationwide Children's Hospital Columbus, Ohio, United States

OHSU Doernbecher Children's Hospital Portland, Oregon, United States

View Trial Details

Active, not recruiting

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

NCT04017650

Conditions: BRAF NP_004324.2:p.V600E, Colonic Diseases, Colonic Neoplasms, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies

NCT03546426

Conditions: Adenoma, Advanced Cancer, Disease Attributes, +18 more
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy

View Trial Details

Completed

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT03586661

Conditions: Adnexal Diseases, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +32 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

NCT03154190

Conditions: Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +146 more
Locations: Virginia K Crosson Cancer Center Fullerton, California, United States

View Trial Details

Completed

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

NCT03990571

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Adenoid Cystic, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive

NCT01737450

Conditions: Disease Attributes, Disease Progression, Head and Neck Neoplasms, +9 more
Locations: Hopital St André Bordeaux, France

Hôpital BEAUJON Clichy, France

Centre Oscar Lambret Lille, France

Centre Léon Bérard Lyon, France

View Trial Details

Progressive Disease

Progressive Disease trial results

Related conditions